CLRB - Cellectar Biosciences GAAP EPS of -$3.11 misses by $0.28
2024-03-27 06:47:52 ET
More on Cellectar Biosciences
- Cellectar Biosciences: A Shoestring Opportunity You're About To Miss
- Cellectar stock climbs 8% on results for CNS malignancy therapy
- Cellectar Biosciences gains on pivotal data for radiotherapy
- Seeking Alpha’s Quant Rating on Cellectar Biosciences
- Historical earnings data for Cellectar Biosciences